Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Potassium voltage-gated channel subfamily H member 2

The KCNH2 gene encodes a potassium channel that is involved in cardiac conduction. Mutations cause autosomal dominant cardiac arrhythmias such al long and short QT syndrome.

Genetests:

Clinic Method Carrier testing
Turnaround 5 days
Specimen type genomic DNA
Clinic Method Massive parallel sequencing
Turnaround 25 days
Specimen type genomic DNA
Research Method Genomic sequencing of the entire coding region
Turnaround 25 days
Specimen type genomic DNA
Research Method Multiplex Ligation-Dependent Probe Amplification
Turnaround 25 days
Specimen type genomic DNA

Related Diseases:

Short QT syndrome 1
KCNH2
Long QT syndrome 02
KCNH2

References:

1.

Kupershmidt S et al. (2002) Defective human Ether-à-go-go-related gene trafficking linked to an endoplasmic reticulum retention signal in the C terminus.

external link
2.

Benson DW et al. (1996) Missense mutation in the pore region of HERG causes familial long QT syndrome.

external link
3.

Satler CA et al. (1996) Novel missense mutation in the cyclic nucleotide-binding domain of HERG causes long QT syndrome.

external link
4.

Li X et al. (1997) The human delta1261 mutation of the HERG potassium channel results in a truncated protein that contains a subunit interaction domain and decreases the channel expression.

external link
5.

Tanaka T et al. (1997) Four novel KVLQT1 and four novel HERG mutations in familial long-QT syndrome.

external link
6.

Satler CA et al. (1998) Multiple different missense mutations in the pore region of HERG in patients with long QT syndrome.

external link
7.

Itoh T et al. (1998) Genomic organization and mutational analysis of HERG, a gene responsible for familial long QT syndrome.

external link
8.

Splawski I et al. (1998) Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1.

external link
9.

Larsen LA et al. (2000) Long QT syndrome with a high mortality rate caused by a novel G572R missense mutation in KCNH2.

external link
10.

Kagan A et al. (2000) The dominant negative LQT2 mutation A561V reduces wild-type HERG expression.

external link
11.

Nakajima T et al. (2000) Characterization of S818L mutation in HERG C-terminus in LQT2. Modification of activation-deactivation gating properties.

external link
12.

Yoshida H et al. (2001) Bradycardia-induced long QT syndrome caused by a de novo missense mutation in the S2-S3 inner loop of HERG.

external link
13.

Priori SG et al. (1999) Low penetrance in the long-QT syndrome: clinical impact.

external link
14.

Paulussen A et al. (2002) A novel mutation (T65P) in the PAS domain of the human potassium channel HERG results in the long QT syndrome by trafficking deficiency.

external link
15.

Johnson WH et al. (2003) Clinical, genetic, and biophysical characterization of a homozygous HERG mutation causing severe neonatal long QT syndrome.

external link
16.

Ficker E et al. (2003) Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG.

external link
17.

Gong Q et al. (2005) Degradation of trafficking-defective long QT syndrome type II mutant channels by the ubiquitin-proteasome pathway.

external link
18.

Gong Q et al. (2006) Mechanisms of pharmacological rescue of trafficking-defective hERG mutant channels in human long QT syndrome.

external link
19.

Vatta M et al. (2006) Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.

external link
20.

Xiao J et al. (2007) MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts.

external link
21.

Tenenbaum M et al. (2008) Identification of the gene causing long QT syndrome in an Israeli family.

external link
22.

Huffaker SJ et al. (2009) A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia.

external link
23.

Rihel J et al. (2010) Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation.

external link
24.

Gianulis EC et al. (2011) Rescue of aberrant gating by a genetically encoded PAS (Per-Arnt-Sim) domain in several long QT syndrome mutant human ether-á-go-go-related gene potassium channels.

external link
25.

None (1996) The inconstancy of the human heart.

external link
26.

Zareba W et al. (1998) Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group.

external link
27.

Berthet M et al. (1999) C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence.

external link
28.

Jongbloed RJ et al. (1999) Novel KCNQ1 and HERG missense mutations in Dutch long-QT families.

external link
29.

Splawski I et al. (2000) Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.

external link
30.

Yang P et al. (2002) Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.

external link
31.

Westenskow P et al. (2004) Compound mutations: a common cause of severe long-QT syndrome.

external link
32.

Tester DJ et al. (2005) Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.

external link
33.

Millat G et al. (2006) Spectrum of pathogenic mutations and associated polymorphisms in a cohort of 44 unrelated patients with long QT syndrome.

external link
34.

Curran ME et al. (1995) A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.

external link
35.

Zhou Z et al. (1998) HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects.

external link
36.

Moss AJ et al. (2002) Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel.

external link
37.

Lees-Miller JP et al. (2003) Selective knockout of mouse ERG1 B potassium channel eliminates I(Kr) in adult ventricular myocytes and elicits episodes of abrupt sinus bradycardia.

external link
38.

Amin AS et al. (2008) Fever-induced QTc prolongation and ventricular arrhythmias in individuals with type 2 congenital long QT syndrome.

external link
39.

Itzhaki I et al. (2011) Modelling the long QT syndrome with induced pluripotent stem cells.

external link
40.

Hong K et al. (2005) Short QT syndrome and atrial fibrillation caused by mutation in KCNH2.

external link
41.

Gussak I et al. (2000) Idiopathic short QT interval: a new clinical syndrome?

external link
42.

Gaita F et al. (2003) Short QT Syndrome: a familial cause of sudden death.

external link
43.

Brugada R et al. (2004) Sudden death associated with short-QT syndrome linked to mutations in HERG.

external link
44.

Trudeau MC et al. (1995) HERG, a human inward rectifier in the voltage-gated potassium channel family.

external link
45.

Sanguinetti MC et al. (1995) A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.

external link
46.

Warmke JW et al. (1994) A family of potassium channel genes related to eag in Drosophila and mammals.

external link
47.

Thomas PJ et al. (1995) Defective protein folding as a basis of human disease.

external link
48.

Smith PL et al. (1996) The inward rectification mechanism of the HERG cardiac potassium channel.

external link
49.

Orphanet article

Orphanet ID 122777 external link
50.

NCBI article

NCBI 3757 external link
51.

OMIM.ORG article

Omim 152427 external link
52.

Wikipedia article

Wikipedia EN (HERG) external link
Update: Aug. 14, 2020
Copyright © 2005-2020 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues